NextTrial today announced the official launch of NextTrial One, a unified intelligence platform for life sciences designed to accelerate innovation and data-driven decision-making across ...

Ensuring data quality and harmonization transforms regulatory reporting from a compliance burden into a strategic asset, enabling confident decision-making and reducing compliance costs. Leveraging ...

The advent of artificial intelligence (AI) and data-driven methodologies has triggered a wave of transformation in regulatory compliance and quality assurance for the development of medical devices.

Compliance is, for sure, no longer only legal but also a significant cornerstone in this interwoven world to maintain trust, protect reputation and ensure seamless operations. Most global enterprises ...

The investment will accelerate Redica’s expansion of its Catalyst Platform™ and the Redica Supplier Data Network™ (SDN), advancing AI-driven workflows, predictive quality and regulatory intelligence, ...

Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data Protection (hereinafter referred to as the 'Draft for Comments'), ...